BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12163193)

  • 21. Th1 dominance in HAM/TSP and the optico-spinal form of multiple sclerosis versus Th2 dominance in mite antigen-specific IgE myelitis.
    Horiuchi I; Kawano Y; Yamasaki K; Minohara M; Furue M; Taniwaki T; Miyazaki T; Kira Ji
    J Neurol Sci; 2000 Jan; 172(1):17-24. PubMed ID: 10620655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased type 2 cytokine expression by both CD4+ CD45RO+ T cells and CD8+ CD45RO+ T cells in blood circulation is associated with high serum IgE but not with atopic dermatitis.
    Sato A; Tsuji K; Yamamura M; Morita Y; Kanzaki H; Tada J; Makino H; Arata J
    J Invest Dermatol; 1998 Dec; 111(6):1079-84. PubMed ID: 9856820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease.
    Clerici M; Saresella M; Trabattoni D; Speciale L; Fossati S; Ruzzante S; Cavaretta R; Filippi M; Caputo D; Ferrante P
    J Neuroimmunol; 2001 Dec; 121(1-2):88-101. PubMed ID: 11730945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of CD4+TNF{alpha}+IL-2-T cells in cerebrospinal fluid of multiple sclerosis patients.
    Shi N; Kawano Y; Matsuoka T; Mei F; Ishizu T; Ohyagi Y; Kira J
    Mult Scler; 2009 Jan; 15(1):120-3. PubMed ID: 18755820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
    Peelen E; Thewissen M; Knippenberg S; Smolders J; Muris AH; Menheere P; Tervaert JW; Hupperts R; Damoiseaux J
    J Neuroimmunol; 2013 May; 258(1-2):77-84. PubMed ID: 23517930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J
    J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-1-associated myelopathy.
    Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
    J Neuroimmunol; 1991 Dec; 35(1-3):285-93. PubMed ID: 1955570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon gamma and interleukin 4 producing T cells in peripheral blood of multiple sclerosis patients undergoing immunomodulatory treatment.
    Franciotta D; Zardini E; Bergamaschi R; Andreoni L; Cosi V
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):123-6. PubMed ID: 12486283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The activation of memory CD4(+) T cells and CD8(+) T cells in patients with multiple sclerosis.
    Okuda Y; Okuda M; Apatoff BR; Posnett DN
    J Neurol Sci; 2005 Aug; 235(1-2):11-7. PubMed ID: 15972217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis.
    Cho I; Sugimoto M; Mita S; Tokunaga M; Imamura F; Ando M
    Am J Trop Med Hyg; 1995 Oct; 53(4):412-8. PubMed ID: 7485696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS.
    Killestein J; Eikelenboom MJ; Izeboud T; Kalkers NF; Adèr HJ; Barkhof F; Van Lier RA; Uitdehaag BM; Polman CH
    J Neuroimmunol; 2003 Sep; 142(1-2):141-8. PubMed ID: 14512173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients.
    Jenne L; Kilwinski J; Scheffold W; Kern P
    Clin Exp Immunol; 1997 Jul; 109(1):90-7. PubMed ID: 9218830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
    Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
    J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.
    Alberti C; Cartier L; Valenzuela MA; Puente J; Tanaka Y; Ramirez E
    J Med Virol; 2011 Sep; 83(9):1641-9. PubMed ID: 21739457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).
    Osame M
    J Neurovirol; 2002 Oct; 8(5):359-64. PubMed ID: 12402162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1.
    Pinheiro SR; Martins-Filho OA; Ribas JG; Catalan-Soares BC; Proietti FA; Namen-Lopes S; Brito-Melo GE; Carneiro-Proietti AB;
    Am J Ophthalmol; 2006 Nov; 142(5):811-15. PubMed ID: 16989761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
    Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
    Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
    Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased CD8+ central memory T cells in patients with multiple sclerosis.
    Liu GZ; Fang LB; Hjelmström P; Gao XG
    Mult Scler; 2007 Mar; 13(2):149-55. PubMed ID: 17439879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.